Relay Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue 2,500,000 shares at a price of $12 per share for the gross proceeds of $30 million on January 8, 2024. The transaction will include participation from new investor, Nextech. The transaction is expected to close on January 10, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.42 USD | +1.74% | -8.81% | -41.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.69% | 852M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it expects to receive $30 million in funding